Table 3.

Echocardiographic parameters during follow-up

	Baseline			3 months FU		6 months FU		12 months FU		Two-way ANOVA
	MSC (n = 8)	Control (n = 38)	P value*	MSC (n = 8)	Control (n = 38)	MSC (n = 8)	Control (n = 38)	MSC (n = 8)	Control (n = 38)	P value**
LVESV (mL)	50 ± 9	58 ± 18	0.21	49 ± 14	58 ± 22	47 ± 11	54 ± 23	45 ± 14	52 ± 26	0.87
LVEDV (mL)	95 ± 16	105 ± 29	0.36	101 ± 26	112 ± 28	102 ± 20	110 ± 24	104 ± 30	108 ± 28	0.46
LVEF (%)	48 ± 2	45 ± 9	0.38	52 ± 2	49 ± 11	54 ± 4	50 ± 10	57 ± 3	50 ± 12	0.28
WMSI	1.6 ± 0.2	1.7 ± 0.3	0.28	1.4 ± 0.3	1.5 ± 0.3	1.4 ± 0.5	1.4 ± 0.3	1.2 ± 0.1	1.4 ± 0.3	0.20

LVESV left ventricular end-systolic volumes, LVEDV left ventricular end-diastolic volumes, LVEF left ventricular ejection fractions, WMSI Wall Motion Score Index, FU follow-up

*P values are given for the comparison of parameters between controls and MSC-treated patients at baseline

** P values are given for the comparison of parameters between controls and MSC-treated patients during 12 months follow-up